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Self-conscious emotions such as pride, shame and embarrassment have received an increase 
 
in research interest over the past thirty years due to their central role in regulating and 
 
motivating an individual’s thoughts, feelings and behaviours (Tracy & Robbins, 2004). 
 
Furthermore, research has suggested that self-conscious emotions, even those which on the 
 
surface might seem associated with negative consequences, can motivate people to work hard 
 
to achieve their goals and to behave in socially appropriate ways (Leith & Baumeister, 1998). 
 
For example, individuals who experience feelings of guilt also tend to display prosocial 
 
behaviours such as empathy, altruism and caregiving (Tangney, Stuewig & Mashek, 2007). 
 
Therefore, this would suggest that self-conscious emotions have a social function which 
 
enables individuals to behave in ways which promote positive interpersonal relationships. 
 




One proposed explanation for this is social identity theory (Tajfel, 1979) 
 
which suggests that self-conscious emotions are related to an individual’s self-identity. In 
 
particular, Borckner and Higgins (2001) proposed that individuals have different perceptions 
 
of themselves such as an ‘ideal’ self and ‘ought self’. For example, an individual’s ‘ought 
 
self’ refers to their perceived duties, obligations and responsibilities. Conversely their ‘ideal 
 
self’ reflects’ their hopes, wishes and aspirations. However, there can often be discrepancies 
 
between the two internal representations of self which can create emotional conflict for the 
 
individual. Additionally, there can be negative emotional consequences for individuals and 
 
how they perceive themselves if they perceive themselves as not meeting the standards of 
 
either their ‘ought self ‘or ‘ideal self’ (Brockner & Higgins, 2001). Moreover, a positive 
 
social evaluation and consistency between an individual’s self and social identity’s can illicit 
 
positive social emotions such as pride (Tracy & Robbins, 2004). Therefore, this would 
 
suggest that self-conscious emotions derive from an individual’s perception of how congruent 
 





In addition to the growing body of research regarding the impact of self-conscious 
 
emotions, there is also a growing interest in the impact of self-conscious emotions in 
 
caregivers. For example, research with formal caregivers (healthcare workers) has begun to 
 
study the impact of self-compassion on empathy and compassionate practice towards 
 
individuals for whom they professionally care (Spandler & Stickley, 2011). However, this 
 
research base has not yet explored this in relation to informal caregivers such as family 
 
members. Therefore, it could be hypothesised that the differences in roles and expectations 
 
between formal and informal caregivers may result in differences in their own self-conscious 
 
emotions and how this impacts on their experience of their situation. 
 
 
Across the world, health and social care systems are facing the challenge of caring for 
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an increasingly aging population (Stolz, Uden & Willman, 2004). Moreover, as many people 
 
are living longer, the number of individuals who experience chronic health conditions such as 
 
dementia is also increasing. Current rates of dementia are estimated at 47.5 million people 
 
worldwide, however this figure is set to triple by 2050 (World Health Organisation, 2015). 
 
Therefore, with dementia affecting a large proportion of people across the world there are 
 
significant social and financial implications for individuals, communities and health care 
 
systems. Specifically, increasing levels of care are being provided by family members of 
 
those with dementia as services struggle to meet the increasing need. 
 
 
Consequently, in the early stages of dementia, support is often provided by family 
 
members, in particular partners. The support provided by partners may be a combination of 
 
emotional, financial and/or practical (Contador, Fernandez-Calvo, Palenzuela, Migueis & 
 
Ramos, 2012). Additionally many families choose, or in some cases have no option, to care 
 
for the individual at home as thresholds for service provision continue to rise. Moreover, 
 
individuals with dementia are encouraged to remain in their home with support for as long as 
 
possible, as research has suggested that individuals who are cared for at home have lower 
 
morbidity and mortality rates than those in institutional settings (van Houtven & Norton, 
 
2004). However, this can have physical and mental health implications for the family 
 
member who is providing the care. 
 
 
The current study was designed with a qualitative methodology in order to explicitly 
 
investigate how partners of people with dementia feel about themselves. It is suggested that 
qualitative methodology is utilised in the exploratory stages of research (Brown & Lloyd, 2001) and 
in research areas where there are significant gaps in current research knowledge (Elliott, Fischer & 
Rennie, 1999). Additionally, it is anticipated that a methodology such as interpretative 
phenomenological analysis (Smith, Flowers & Larkin, 2009) will capture the experiences of 
individuals who care for their partner with dementia and allow them to openly express their stories 
with the researcher. Semi-structured interviewing will be used to explore participants’ experiences 
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of self-conscious emotions in the context of their partner’s diagnosis of dementia. These subjective 









The study will aim to recruit a maximum of 10 participants; however a minimum of six will 
 
need to be achieved to enable the results to be thoroughly analysed. If more than 10 
 
individuals approach the researcher to take part in the study, the first 10 individuals who can 
 
attend an interview schedule will be recruited. With regards to inclusion criterion all 
 
participants will be partners of people with a diagnosis of dementia. Furthermore, the individual 
with the diagnosis of dementia should be over the age of 65 years old, as the experience of 
individuals with a partner who has an early onset dementia may differ from those diagnosed with 
dementia later in life. 
All participants will be under the care of a memory service, which provides specific 
 
support for individuals with memory difficulties. Moreover, in this case ‘partner’ refers to an 
 
individual who is in a relationship with someone with a dementia diagnosis with whom they 
 
have been cohabiting for at least five years prior to the diagnosis of dementia. Additionally, 
 




In terms of exclusion criteria, individuals will not be included in the study if their 
 
partner no longer lives in the same property as them. Individuals who themselves have a 
 
diagnosis of dementia will also not be included in the study due to potential differences in the 
 





As this study is interested in the experiences of individuals, it will be of qualitative design 
 
4-6  ETHICS FORMS  
 
 
using a semi-structured interview format. Participants will be interviewed individually by the 
 
lead researcher and transcripts will be analysed using the IPA approach described by Smith, 
 






Posters will be displayed within three memory clinics from the North-West region of the UK 
 
(within the same NHS trust) asking for participation from partners whose partner has a 
 
diagnosis of dementia. In addition, research information packs will be distributed to partners 
 
of patients with a dementia diagnosis, at the end of clinic appointments by the memory nurse. 
 
Prior to the advertisement of the study, the researcher will meet with the memory nurses to 
 
give an overview of the study and also details of any inclusion and exclusion criteria. 
 
 
Therefore, participants will choose to opt in to the research study and the researcher 
 
will not be aware of participant details until they contact the researcher. Potential 
 
participants can contact the researcher via email, mobile telephone or complete the 
 
expression of interest form for the researcher to contact them. This initial contact does not 
 
assume consent to participate in the study, instead it is an opportunity for participants to ask 
 
the researcher more information about the study. At no point during or following completion 
 
of the study will staff from the memory service be aware of the identities of the participants. 
 
 
Participants will be interviewed individually by the lead researcher using a semi- 
 
structured interview format. Each participant will be allocated a maximum of sixty minutes 
 
to be interviewed, including time to discuss the participant information sheet, sign the 
 
consent form and answer any questions. It is anticipated that a minimum of thirty minutes 
 
will be required to adequate data to be gained from each interview, however participants can 
 
ask for the interview to be stopped at any point or the researcher may stop the interview if 
 
they feel that the participant is becoming distressed. Participants will be informed at the start 
 
of the meeting that all of the time that is spent with the researcher will be recorded using a 




digital recorder, including any conversations before or after the interview. 
 
 
Where possible all interviews will take place on NHS sites, primarily Merseycare 
 
NHS Trust sites, where the three memory services are based. However, in order to ensure the 
 
study is more accessible for participants some interviews may be held at local GP surgeries or 
 
within their own homes. 
 
 
The recordings will be transcribed by hand by the researcher. The academic 
 
supervisor of the project will also listen to an anonymised version of the first interview and 
 
comment on the transcription techniques. Once each interview has been transcribed, the 
 
recording will be deleted. The transcriptions will be saved in password protected documents 
 
on the university’s Virtual Private Network (VPN) until the project has been completed. 
 
Following the completion of the project, all electronic data will be encrypted and transferred 
 
securely to the university’s research coordinator who will save the files in password-protected 
 
file space on the university VPN. After a ten year period, all data will be destroyed. 
 
Once transcribed, IPA will be used to analyse the data, as it will explore how 
 
participants are making sense and experience this particular situation. Key demographic 
 
information will be noted such as age, gender, length of relationship, current support 
 
networks and when their partner received a diagnosis of dementia, in order to acknowledge 
 
factors which may have an impact on how participants experience their current situation. 
 
However, in order to maintain some anonymity, participants will be invited to create an 
 






The transcribed data will be analysed using IPA which aims to explore the experiences of 
 
participants and how they make sense of their current situation. The emphasis of this 
 
approach is for the researcher to become emerged in the participants’ psychological world, 
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which includes their beliefs, identity and own constructs of the world they live in (Smith, 
 
2003). The verbatim accounts of participants will be transcribed and analysed using IPA 
 
(Smith et al., 2009). This particular analytic process is described as an iterative and inductive 
 
approach that involves six flexible stages. 
 
 
The first stage of the analysis is to read each of the transcripts individually a number 
 
of times in order for the researcher to become familiar with the story and language of each 
 
individual participant. Each time that the text is read the researcher will write comments and 
 
thoughts in the left margin of the transcribed text, highlighting any areas of interest or 
 
potential significance. Throughout this process the researcher may notice specific language 
 
used, similarities, contradictions and repeated themes in what the participant is saying. 
 
Following the repeated reading of the entire transcript, the researcher will then start to 
 
develop initial themes in the right margin of each transcript. These themes should be 
 
developed from the original comments made in stage one, however they should be more 
 
concise and use more psychological terminology. Furthermore, it is important that the 
 
researcher continually refers back to the original comments made by the participants to 
 
ensure that the themes are capturing the meaning expressed. This process should be 
 
continued for the whole transcript and consequently any similar themes identified should be 
 
given the same theme title. 
 
 
Following the identification of the emergent themes, the researcher will begin to look 
 
for connections between them. Specifically, the researcher will start to list themes in an order 
 
which has theoretical relevance or may appear more significant than others. As with previous 
 
stages it is imperative that the researcher is frequently referring back to the original 
 
transcripts to ensure that the connections are not significantly removed from the actual words 
 
of the participants. In order to support this process, the researcher may collate the direct 
 
participant quotes which relate to each theme and continually review and edit these groupings 
 
as the themes develop further. The fourth stage of this process is to produce a table of 




emergent themes and to organise them in clusters of similar themes. These clusters represent 
 
superordinate themes which should be given a name representing the participants’ original 
 
quotes and initial themes. At this stage of the analysis it is important that the researcher 
 
develops a list of identifiers, in the form of page numbers and key words, for each theme 
 
indicating the exact location of the associated participant quote. 
 
 
The fifth stage of this process involves the researcher moving beyond the first 
 
participant’s transcript to the analysis of the remaining transcripts. As with the first stage of 
 
the analysis, the researcher will read each of the transcripts individually a number of times in 
 
order to become familiar with the language used and potentially significant quotes. 
 
Following this the researcher will identify any emerging themes in each transcript which are 
 
similar to those identified in the first participant’s account. However, it is important that the 
 
researcher acknowledges any new themes which may occur in the later transcripts rather than 
 
attempting to fit them into the existing themes. Once themes and supporting quotes have 
 
been identified across the transcripts, a table of superordinate themes is constructed. These 
 
superordinate themes are categorised in terms of the richness and connectedness of the data 
 
contained within each theme. 
 
 
The final stage of the analysis is ensuring that the write up of the findings is 
 
representative of the accounts given by the participants. This is done by using the table of 
 
themes as a basis for the write up and writing a narrative argument interspersed with verbatim 
 
accounts from participants to support the argument. Moreover, it is important in the write up 
 
to distinguish between what exactly each participant has said and the interpretations made by 
 
the researcher. Throughout this development of the narrative the researcher will start to link 
 
the superordinate themes to theories which will be expanded upon in the discussion section of 
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Practical Issues: (costs/logistics) 
 
 
Potential participants will be provided with self-addressed envelopes that can be used to 
 
return to expression of interest forms to the researcher. This cost will be covered by a 
 
freepost address given by Lancaster Doctorate in Clinical Psychology (DClinPsy) 
 
programme, Lancaster University. It is proposed that all participants are interviewed within 
 
Merseycare NHS Trust sites, where the three memory services are based as at least one of 
 
these locations are familiar to all participants. However, should participants struggle to 
 
attend one of these locations, local GP surgeries or participant homes may be used to conduct 
 
the interviews. In cases where interviews are conducted at GP surgeries or participant homes, 
 
the researcher will adhere to MerseyCare NHS Trust’s lone working policy. This will include 
 
utilising a ‘buddy’ system with another trainee at Lancaster University, with whom they will discuss 
the lone working procedures (page 11 of MerseyCare’s 2015 lone working policy). As per the policy, 
the researcher will provide the buddy with their research mobile phone number, which will be 
switched on throughout the interviews, in addition to a timetable and location of each interview. The 
lead researcher will arrange to telephone the ‘buddy’ prior to the start and at the end of each 
interview. As per the policy, if there is no response from the researcher following the expected end 
time of the interview, the ‘buddy’ will telephone the ‘nominated lead for worker safety’, which in 
this particular case will be the project’s field supervisor (Dr Liliana Loftus). Furthermore, interviews 
will only be conducted during the working week (Monday-Friday) and during office hours (9am-
5pm) to ensure that support can be sought if interviews are conducted in NHS premises.  
Participants will be able to claim up to £20 expenses for travel costs from Lancaster 
University. The researcher will provide expenses forms to participants on the day of 
 












Prior to the start of the interview, issues of confidentiality will be discussed with each 
 
participant. This will involve informing them that all conversations will be confidential 
 
between the researcher, participant and academic supervisor. However, participants will be 
 
informed that should the researcher have any concerns that they or anyone else is at risk, this 
 
information will be shared with the named academic supervisor for an action plan to be 
 
formulated further. Issues of risk may involve physical, psychological, sexual or verbal 
 
abuse, as well as engaging in significant risk taking behaviour that may cause harm to the 
 
individual or other people. The researcher will always aim to discuss any breach of 
 
confidentiality with participants prior to discussing the information with a third party, so that 
 
a collaborative way of disclosing the information can be devised. 
 
 
Additionally, as consent is not being sought from the individual who has a diagnosis 
 
of dementia, participants will be asked not to focus upon specific behaviours that their partner 
 
may exhibit, but instead talk about how they manage their own feelings and ways of coping. 
 
Participants will be reminded of this in the information sheet, at the start of the interview and 
 
during the interview if necessary. 
 
 
It is not anticipated that the research will cause any significant distress for 
 
participants, however the researcher is aware that participating in this research may bring up 
 
some challenging issues for individual participants. However, if this was to happen during an 
 
interview, participants would be given the option for the interview to be stopped, but they 
 
will be made aware that any further conversations will continue to be recorded. This is to 
 
protect both the participant and researcher if any further action needs to be taken. There are 
 
some limits to confidentiality: if what is said in the interview concerns significant risks to the 
 
participant, or someone else. However, if the lead researcher feels that there is an immediate risk to 
the individual being interviewed or anyone else, local emergency services will be contacted. 
Additionally, should the researcher become concerned that there is a safeguarding concern 
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underlying the distress of the participant, then the researcher will follow Mereycare’s safeguarding 
vulnerable adults policy.  If possible, the researcher will inform the participant of this breach of 
confidentiality before it occurs.  Participants will not be offered any clinical support by the 
researcher but will be provided with the contact details of Sefton Carers Centre and the Alzheimer’s 
Society who can provide support and advice for individuals who care for others. All participants will 
be reminded on these contact details at the end of each interview, in addition the details documented 
on the participant information sheet. Furthermore, a letter will be sent to all participant’s GPs 
informing them of their participation in the study. This will allow them to provide any additional 
support either currently or in the future. 
Additionally, when participants are interviewed for the research, they will be offered 
 
the opportunity to create a pseudonym for the purpose of the study. Throughout the 
 
interviews and the final write up of the study, the researcher will refer to the participants by 
 
their pseudonym and be mindful of including any identifiable characteristics. 
 
 
It is not anticipated that there will be any negative effects for the researcher following 
 
the interviews, however additional support may be sought from clinical tutors within 
 






Activity Approximate timescale 
Ethical Application February-April 2016 
Recruitment of participants April-June 2016 
Conduct interviews April-June 2016 
Analyse Data May-July 2016 
Write up draft report June-July 2016 
Finalise report August 2016 
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their own feelings and experiences. Participants will be reminded of this in the information sheet, at the start of the 
interview and during the interview if necessary. 
 
It is not anticipated that the research will cause any significant distress for participants, the researcher is aware that 
participating in this research may bring up some challenging issues for individual participants. However, if this was to 
happen during an interview, participants would be given the option for the interview to be stopped, but they will be made 
aware that any further conversations will continue to be recorded. Participants will not be offered any clinical support by 
the researcher but will be provided with the contact details of Sefton Carers Centre and the Alzheimer’s Society who 
can provide support and advice for individuals who care for others. Participants will also be advised to seek support 
from their GP. 
 
 
A6-3. Proportionate review of REC application The initial project filter has identified that your study may be suitable for 
proportionate review by a REC sub-committee. Please consult the current guidance notes from NRES and indicate whether 
you wish to apply through the proportionate review service or, taking into account your answer to A6-2, you consider there are 
ethical issues that require consideration at a full REC meeting. 
 
Yes - proportionate review  No - review by full REC meeting 
 
Further comments (optional): 
 
Note: This question only applies to the REC application. 
 
 










A7. Select the appropriate methodology description for this research. Please tick all that apply: 
 






















Questionnaire, interview or observation study 
 
Randomised controlled trial 
 




A10. What is the principal research question/objective? Please put this in language comprehensible to a lay person. 
 
This study aims to explore how partners of individuals diagnosed with Alzheimer's disease, vascular dementia or 
mixed dementia understand self-conscious emotions. 
 
 
A11. What are the secondary research questions/objectives if applicable? Please put this in language comprehensible to  





A12. What is the scientific justification for the research? Please put this in language comprehensible to a lay person. 
 
It is anticipated that this information will develop our current understanding of the emotional experiences of partners, 
which may impact upon their psychological and physical wellbeing. Furthermore, these findings aim to inform the type 
of support systems which should be in place around the individual with dementia and their partner. The findings may 
also inform the pathway for future research in this area. 
 
 
A13. Please summarise your design and methodology. It should be clear exactly what will happen to the research 
participant, how many times and in what order. Please complete this section in language comprehensible to the lay person. 
Do not simply reproduce or refer to the protocol. Further guidance is available in the guidance notes. 
 
Posters will be displayed within three memory clinics from the North-West region of the UK (within the same NHS trust) 
asking for participation from partners whose partner has a diagnosis of dementia. In addition, research information packs 
will be distributed to partners of patients with a dementia diagnosis, at the end of clinic appointments by the memory 
nurse. Prior to the advertisement of the study, the researcher will meet with the memory nurses to give an overview of 
the study and also details of any inclusion and exclusion criteria.  
Therefore, participants will choose to opt in to the research study and the researcher will not be aware of participant 
details until they contact the researcher. Potential participants can contact the researcher via email, mobile telephone or 
complete the expression of interest form for the researcher to contact them. This initial contact does not assume consent 
to participate in the study, instead it is an opportunity for participants to ask the researcher more information about the 
study. At no point during or following completion of the study will staff from the memory service be aware of the identities 
of the participants. 
 
Participants will be interviewed individually by the lead researcher using a semi-structured interview format. Each 
participant will be allocated a maximum of sixty minutes to be interviewed, including time to discuss the participant 
information sheet, sign the consent form and answer any questions. It is anticipated that a minimum of thirty minutes will 








    
 
stopped at any point or the researcher may stop the interview if they feel that the participant is becoming distressed. 
Participants will be informed at the start of the meeting that all of the time that is spent with the researcher will be 
recorded using a digital recorder, including any conversations before or after the interview. 
 
Where possible all interviews will take place on NHS sites, primarily Merseycare NHS Trust sites, where the three 
memory services are based. However, in order to ensure the study is more accessible for participants some 
interviews may be held at local GP surgeries or within their own homes.  
The recordings will be transcribed by hand by the researcher. The academic supervisor of the project will also listen to 
an anonymised version of the first interview and comment on the transcription techniques. Once each interview has 
been transcribed, the recording will be deleted. The transcriptions will be saved in password protected documents on 
the university’s Virtual Private Network (VPN) until the project has been completed. Following the completion of the 
project, all electronic data will be encrypted and transferred securely to the university’s research coordinator who will 
save the files in password-protected file space on the university VPN. After a ten year period, all data will be destroyed. 
 
 
Once transcribed, IPA will be used to analyse the data, as it will explore how participants are making sense and 
experience this particular situation. Key demographic information will be noted such as age, gender, length of 
relationship, current support networks and when their partner received a diagnosis of dementia, in order to 
acknowledge factors which may have an impact on how participants experience their current situation. However, in 
order to maintain some anonymity, participants will be invited to create an alternative name which they will be referred 





A14-1. In which aspects of the research process have you actively involved, or will you involve, patients, service 
users, and/or their carers, or members of the public? 
 
Design of the research 
 
Management of the research 
 
Undertaking the research 
 
Analysis of results 
 
Dissemination of findings 
 
None of the above 
 
 
Give details of involvement, or if none please justify the absence of involvement.  
One member of Lancaster University Public Involvement Network (LUPIN) has been involved in the design of 
materials for this study. Additionally, it is anticipated that one member of the service user group (LUPIN) will engage in 
a mock interview with the lead researcher as a trial of the interview schedule. 
 
 




A17-1. Please list the principal inclusion criteria (list the most important, max 5000 characters). 
 
All participants will be partners of people with a diagnosis of dementia and under the care of a memory service. 
Specifically, in this case partner refers to individuals who are legally married or who have been cohabiting prior to the 
diagnosis of dementia. Additionally, all participants must be over the age of eighteen and able to provide consent to 
participate in the study. 
 
 
A17-2. Please list the principal exclusion criteria (list the most important, max 5000 characters). 
 
In terms of exclusion criteria, individuals will not be included in the study if their partner no longer lives in the same 
property as them. Individuals who themselves have a diagnosis of dementia will also not be included in the study due to 
potential differences in the dynamics of the relationship where both individuals have a diagnosis of dementia. Moreover, 
partners of individuals who have a diagnosis of dementias other than Alzheimer’s, vascular or mixed Alzheimer’s-









RESEARCH PROCEDURES, RISKS AND BENEFITS 
 
A18. Give details of all non-clinical intervention(s) or procedure(s) that will be received by participants as part of 
the research protocol. These include seeking consent, interviews, non-clinical observations and use of questionnaires. 
 
Please complete the columns for each intervention/procedure as follows: 
 
1. Total number of interventions/procedures to be received by each participant as part of the research protocol. 
 
2. If this intervention/procedure would be routinely given to participants as part of their care outside the research, 
how many of the total would be routine? 
 
3. Average time taken per intervention/procedure (minutes, hours or days) 
 
4. Details of who will conduct the intervention/procedure, and where it will take place. 
 
 Intervention or procedure 1 2 3 4  
 Seeking consent 1 0 5 minutes The lead researcher will seek consent from each participant. 
 1:1 interviews 1 0 60 minutes The lead researcher will conduct all of the interviews. 
       
       
       
 
A21. How long do you expect each participant to be in the study in total? 
 
Once the participant has conducted the lead researcher to express their interest in the study, it is anticipated that 
participants will be interviewed within 28 days maximum. It is anticipated that a minimum of thirty minutes will be 
required to adequate data to be gained from each interview, however participants can ask for the interview to be 
stopped at any point or the researcher may stop the interview if they feel that the participant is becoming distressed. 
Following this, the participants will have no further contact with the study unless they wish to withdraw their data. 
 
 
A22. What are the potential risks and burdens for research participants and how will you minimise them? 
 
For all studies, describe any potential adverse effects, pain, discomfort, distress, intrusion, inconvenience or changes 
to lifestyle. Only describe risks or burdens that could occur as a result of participation in the research. Say what steps 
would be taken to minimise risks and burdens as far as possible. 
 
It is not anticipated that the research will cause any significant distress for participants, however the researcher is aware 
that participating in this research may bring up some challenging issues for individual participants. However, if this was 
to happen during an interview, participants would be given the option for the interview to be stopped, but they will be 
made aware that any further conversations will continue to be recorded. This is to protect both the participant and 
researcher if any further action needs to be taken. Prior to the interviews starting, a clinical psychologist within the 
service will be identified, who can be contacted if the researcher has any immediate concerns about risks to participants 
or anyone else. Where possible this should be the field supervisor of the project, as they will have more in depth 
knowledge about the study. Participants will not be offered any clinical support by the researcher but will be provided 
with the contact details of Sefton Carers Centre and the Alzheimer’s Society who can provide support and advice for 
individuals who care for others. Participants will also be advised to seek support from their GP. 
 
 
A23. Will interviews/ questionnaires or group discussions include topics that might be sensitive, embarrassing 
or upsetting, or is it possible that criminal or other disclosures requiring action could occur during the study? 
 
 Yes       No 
 
 
A24. What is the potential for benefit to research participants? 
 
While there are no specific benefits for participants taking part in this research, there may be secondary benefits to 
participating in research generally. For example participants will be contributing to a field of research which aims to 
improve the quality of life for individuals in similar situations to themselves. Additionally, participants may find it helpful to 













It is not anticipated that there will be any negative effects for the researcher following the interviews, however additional 
support may be sought from clinical tutors within Lancaster University if necessary. Lancaster's lone working policy will 
also apply. This includes utilising a ‘buddy’ system with another trainee at Lancaster University who will have a timetable 
of the scheduled interviews and location of each interview. The lead researcher will arrange to telephone the ‘buddy’ prior 
to the start and at the end of each interview. Furthermore, interviews will only be conducted during the working week 




RECRUITMENT AND INFORMED CONSENT 
 
In this section we ask you to describe the recruitment procedures for the study. Please give separate details 
for different study groups where appropriate. 
 
A27-1. How will potential participants, records or samples be identified? Who will carry this out and what 
resources will be used?For example, identification may involve a disease register, computerised search of GP records, 
or review of medical records. Indicate whether this will be done by the direct healthcare team or by researchers acting 
under arrangements with the responsible care organisation(s). 
 
In order to recruit participants posters will be displayed within three memory clinics from the North-West region (within 
the same NHS trust) asking for participation from spouses whose partner has a diagnosis of Azheimer's disease, 
valscular or mixed dementia. In addition, research information packs will be given out to spouses of patients with a 
dementia diagnosis, at the end of clinic appointments by the memory nurse. Prior to the advertisement of the study, the 
researcher will meet with the memory nurses to give an overview of the study and also details of any inclusion and 
exclusion criteria. 
 
Therefore, participants will choose to opt-in to the research study and the researcher will not be aware of participant 
details until they contact the researcher. Potential participants can contact the researcher via email, mobile telephone or 
complete the expression of interest form for the researcher to contact them. This initial contact does not assume consent 
to participate in the study, instead it is an opportunity for participants to ask the researcher more information about the 
study. At no point during or following completion of the study will staff from the memory service be aware of the identities 
of the participants. Therefore, no access to patient records will be required. Additionally, within the final write up of the 




A27-2. Will the identification of potential participants involve reviewing or screening the identifiable 
personal information of patients, service users or any other person? 
 
 Yes       No 
 
Please give details below:  
No access to patient notes or data will be required. 
 
 
A28. Will any participants be recruited by publicity through posters, leaflets, adverts or websites? 
 
 Yes       No 
 
If Yes, please give details of how and where publicity will be conducted, and enclose copy of all advertising material 
(with version numbers and dates). 
 
Posters will be displayed within three memory clinics from the North-West region (within the same NHS trust) asking 
for participation from spouses whose partner has a diagnosis of Alzheimer's disease, vascular or mixed dementia. 
Therefore, participants will choose to opt-in to the research study and the researcher will not be aware of participant 
details until they contact the researcher. 
 
 
A29. How and by whom will potential participants first be approached? 
 
Participants will opt in to the study either by completing the expression of interest form, emailing or telephoning the 
lead researcher. If potential participants complete the expression of interest form, the lead researcher will contact 









A30-1. Will you obtain informed consent from or on behalf of research participants? 
 
 Yes       No 
 
If you will be obtaining consent from adult participants, please give details of who will take consent and how it will be 
done, with details of any steps to provide information (a written information sheet, videos, or interactive material). 
Arrangements for adults unable to consent for themselves should be described separately in Part B Section 6, and for 
children in Part B Section 7. 
 
If you plan to seek informed consent from vulnerable groups, say how you will ensure that consent is voluntary and 
fully informed. 
 
All participants will be over eighteen years of age and able to provide informed consent. Prior to providing consent, 
participants will be sent a copy of the 'Participant Information Sheet' and will have the opportunity to ask the lead 
researcher questions about the study. Once participants are happy to take part in the study, prior to the start of the 
interview they will provide written consent via the 'consent form' which details exactly what they are consenting to. 
 
If you are not obtaining consent, please explain why not. 
 
Please enclose a copy of the information sheet(s) and consent form(s). 
 
 
A30-2. Will you record informed consent (or advice from consultees) in writing? 
 
 Yes       No 
 
 
A31. How long will you allow potential participants to decide whether or not to take part? 
 
Participants will have the length of time the interviews intend to run during the study (approximately 2-3 months) to 
decide if they wish to participate. All participants will be offered the opportunity to speak with the researcher via email, 
telephone or in person prior to consenting to take part in the study to discuss their potential participation. 
 
 
A33-1. What arrangements have been made for persons who might not adequately understand verbal explanations or 
written information given in English, or who have special communication needs?(e.g. translation, use of interpreters) 
 
Unfortunately, interpreters will not be used for the purposes of this study. However, participants who require face to 
face meetings with the researcher to discuss their participation in the study. 
 
Additionally, the information about the study will be given t o participants via the information sheet. 
 
 
A35. What steps would you take if a participant, who has given informed consent, loses capacity to consent during 
the study? Tick one option only. 
 
The participant and all identifiable data or tissue collected would be withdrawn from the study. Data or tissue which 
 
is not identifiable to the research team may be retained. 
 
The participant would be withdrawn from the study. Identifiable data or tissue already collected with consent would 
 
be retained and used in the study. No further data or tissue would be collected or any other research procedures carried 
out on or in relation to the participant. 
 
The participant would continue to be included in the study. 
 
Not applicable – informed consent will not be sought from any participants in this research. 
 







If a participant was to lose capacity prior to the interview being conducted, no specific data would have been collated and 
they would therefore be withdrawn from the study with no data utilised. However, if a participant lost capacity following the 
completion of the interview and had previously consented to participate, the data would still be included in the study. 
 






    
 





In this section, personal data means any data relating to a participant who could potentially be identified. It 
includes pseudonymised data capable of being linked to a participant through a unique code number. 
 
Storage and use of personal data during the study 
 
A36. Will you be undertaking any of the following activities at any stage (including in the identification of 
potential participants)?(Tick as appropriate) 
 
Access to medical records by those outside the direct healthcare team 
 
Access to social care records by those outside the direct social care team 
 
Electronic transfer by magnetic or optical media, email or computer networks 
 
Sharing of personal data with other organisations 
 
Export of personal data outside the EEA 
 
Use of personal addresses, postcodes, faxes, emails or telephone numbers 
 
Publication of direct quotations from respondents 
 
Publication of data that might allow identification of individuals 
 
Use of audio/visual recording devices 
 
Storage of personal data on any of the following: 
 




Social Care Service computers 
 










Further details:  
If participants choose to complete the 'expression of interest form' they will be asked to provide a contact telephone 
number on which the researcher can contact them about the study. The telephone number would be used for this 
purpose only and will be destroyed by the researcher once the participant has either taken part in the study or asked 
not to take part. 
 
Within the write- up of this study direct quotes will be utilised as part of the results. However, all participants will be 
referred to by an alternative name and the overall results will be comprised of quotes from all participants, not 
individuals participants. 
 
All interviews will be recorded using audio recording devices, which participants will contact to being used. The data 
recorded will be transferred at the soonest opportunity to an encrypted and password protected laptop, which only the 




A38. How will you ensure the confidentiality of personal data?Please provide a general statement of the policy 
and procedures for ensuring confidentiality, e.g. anonymisation or pseudonymisation of data. 
 
All participants will be referred to throughout the research by their alternative name, which they will create themselves. 
The researcher will also be mindful of participants not being identifiable through individual characteristics (e.g. age, 









A40. Who will have access to participants' personal data during the study? Where access is by individuals outside 
the direct care team, please justify and say whether consent will be sought. 
 
Other than the lead researcher, the academic supervisor, who is not employed by the NHS, will have access to 
participant's data. The academic supervisor will listen to the first recorded interview and check the transcripts. 
Participants will be made aware of this prior to the start of the interview. All interactions between the researcher and 





Storage and use of data after the end of the study 
 
A43. How long will personal data be stored or accessed after the study has ended? 
 
Less than 3 months 
 
3 – 6 months 
 
6 – 12 months 
 
12 months – 3 years 
 
 Over 3 years 
 
 
If longer than 12 months, please justify:  
The interview recordings will be destroyed after the completion  of the final research paper. However, the transcripts 






INCENTIVES AND PAYMENTS 
 
A46. Will research participants receive any payments, reimbursement of expenses or any other benefits or 
incentives for taking part in this research? 
 
 Yes       No 
 
If Yes, please give details. For monetary payments, indicate how much and on what basis this has been determined.  
Participants can claim up to £20 travel expenses for the purposes of the interview. The research will provide expense 
forms to participants during the interview if necessary. 
 
 
A47. Will individual researchers receive any personal payment over and above normal salary, or any other benefits 
or incentives, for taking part in this research? 
 




A48. Does the Chief Investigator or any other investigator/collaborator have any direct personal involvement (e.g. 
financial, share holding, personal relationship etc.) in the organisations sponsoring or funding the research that 
may give rise to a possible conflict of interest? 
 














A49-1. Will you inform the participants’ General Practitioners (and/or any other health or care professional 
responsible for their care) that they are taking part in the study? 
 
        Yes       No 
 
If Yes, please enclose a copy of the information sheet/letter for the GP/health professional with a version number and date. 
 
 
PUBLICATION AND DISSEMINATION 
 
A50. Will the research be registered on a public database? 
 
 Yes       No 
 
Please give details, or justify if not registering the research.  
The researcher intends to submit this research for publication in a peer reviewed  
journal, therefore the abstract and potentially full research pap er will be publicly accessible on the publisher's 
website. 
 
Registration of research studies is encouraged wherever possible.  
You may be able to register your study through your NHS organisation or a register run by a medical research charity, 
or publish your protocol through an open access publisher. If you are aware of a suitable register or other method of 
publication, please give details. If not, you may indicate that no suitable register exists. Please ensure that you have 
entered registry reference number(s) in question A5-1. 
 
 
A51. How do you intend to report and disseminate the results of the study?Tick as appropriate: 
 










Submission to regulatory authorities 
 
Access to raw data and right to publish freely by all investigators in study or by Independent Steering Committee 
 
on behalf of all investigators 
 
No plans to report or disseminate the results 
 
Other (please specify) 
 
 
A53. Will you inform participants of the results? 
 
 Yes       No 
 
Please give details of how you will inform participants or justify if not doing so.  
Participants can choose to have a copy of the final report if they choose so. In this case, they would provide a copy of 
their address to the researcher, which will be kept in a sealed envelope separate to the transcripts and research data. 
Any personal data will be destroyed following the relevant correspondence. 
 
 
5. Scientific and Statistical Review 
 
A54. How has the scientific quality of the research been assessed?Tick as appropriate: 
 
Independent external review 
 
Review within a company 
 







   
 
 
Review within the Chief Investigator's institution or host organisation 
 
Review within the research team 
 




Justify and describe the review process and outcome. If the review has been undertaken but not seen by the 
researcher, give details of the body which has undertaken the review:  
The research design and protocol will be reviewed by the researcher's academic supervisor, prior to the review 
undertaken by the NHS Research Ethics Committee (REC). The academic supervisor will provide only advice and 
guidance on the design and follow through of the study. As part of the research work on the Clinical Psychology Doctoral 
programme, the results will be presented to other students and staff on the course. This will allow for the results to be 
disseminated to other individuals working within Clinical Psychology and also an opportunity for feedback before the 
paper is submitted for publication. 
 
For all studies except non-doctoral student research, please enclose a copy of any available scientific critique reports, 
together with any related correspondence. 
 
For non-doctoral student research, please enclose a copy of the assessment from your educational supervisor/ institution. 
 
 
A59. What is the sample size for the research? How many participants/samples/data records do you plan to study in 
total? If there is more than one group, please give further details below. 
 
Total UK sample size: 10 
 
Total international sample size (including UK): 10 
 
Total in European Economic Area: 10 
 
Further details:  
The study will aim to recruit 10 participants, however a minimum of six will be required in order for inferences and 
subsequent recommendations to be made from the data. 
 
 
A60. How was the sample size decided upon? If a formal sample size calculation was used, indicate how this was done, 
giving sufficient information to justify and reproduce the calculation. 
 
The sample size was chosen in order to provide a sample large enough for adequate qualitative data to be obtained. 
Smith, Flowers and Larkin (2009) suggest that between four and 10 participants is an adequate amount for 
professional doctorate research projects. This is so the data can be adequately interpreted and themes to be 
developed across participant data, without large amounts of data making the process overwhelming. 
 
 
A62. Please describe the methods of analysis (statistical or other appropriate methods, e.g. for qualitative research) 
by which the data will be evaluated to meet the study objectives. 
 
 
The transcribed data will be analysed using IPA which aims to explore the experiences of participants and how they 
make sense of their current situation. The emphasis of this approach is for the researcher to become emerged in the 
participants’ psychological world, which includes their beliefs, identity and own constructs of the world they live in (Smith, 
2003). The verbatim accounts of participants will be transcribed and analysed using IPA (Smith et al., 2009). This 
particular analytic process is described as an iterative and inductive approach that involves six flexible stages. 
 
 
6. MANAGEMENT OF THE RESEARCH 
 
A63. Other key investigators/collaborators. Please include all grant co−applicants, protocol co−authors and other key 





 Title Forename/Initials Surname 
 Dr Liliana Loftus 






   
        
 Qualifications BSc Psychology, Masters Degree, PhD and Doctorate in Clinical Psychology 
 Employer  MerseyCare NHS Trust     
 Work Address South Sefton Neighbourhood Centre     
   Park Road     
   Waterloo, Liverpool     
 Post Code  L22 3XR     
 Telephone  01513308500     
 Fax       
 Mobile       
 Work Email  liliana.loftus@merseycare.nhs.uk     
      
        
      
 A64. Details of research sponsor(s)     
      
      
A64-1. Sponsor      
       
 Lead Sponsor      
 Status: NHS or HSC care organisation Commercial status: 
  Academic     
  Pharmaceutical industry     
  Medical device industry     
  Local Authority     











Name of organisation Lancaster University 
 
Given name Deborah 
 
Family name Knight 
 




Post code LA1 4YT 
 
Country UNITED KINGDOM 
 







Is the sponsor based outside the UK?  
 Yes       No 
 
Under the Research Governance Framework for Health and Social Care, a sponsor outside the UK must appoint a 







   
    
    
    
 
A65. Has external funding for the research been secured? 
 
Funding secured from one or more funders 
 
External funding application to one or more funders in progress 
 








Project that is part of a programme grant 
 
Project that is part of a Centre grant 
 




Other – please state: 
 
 
A67. Has this or a similar application been previously rejected by a Research Ethics Committee in the UK or 
another country? 
 




Please provide a copy of the unfavourable opinion letter(s). You should explain in your answer to question A6-2 how the 
reasons for the unfavourable opinion have been addressed in this application. 
 




 Title Forename/Initials Surname 
 Ms Karen Bruce 
Organisation Merseycare NHS Trust  
Address Building V7  
 Merseycare NHS Trust Offices 
 Kings Business Park, Prescot 
Post Code L34 1PJ  
Work Email Karen.bruce@merseycare.nhs.uk 
Telephone 01514712638  
Fax    
Mobile    
 
Details can be obtained from the NHS R&D Forum website: http://www.rdforum.nhs.uk 
 
 
A69-1. How long do you expect the study to last in the UK? 
 
Planned start date: 01/02/2016 
 
























Other countries in European Economic Area 
 
Total UK sites in study 3 
 
Does this trial involve countries outside the EU?  
 Yes       No 
 
 
A72. Which organisations in the UK will host the research?Please indicate the type of organisation by ticking the box and 
give approximate numbers if known: 
 
NHS organisations in England 1 
NHS organisations in Wales  
NHS organisations in Scotland  
HSC organisations in Northern Ireland  
GP practices in England  
GP practices in Wales  
GP practices in Scotland  
GP practices in Northern Ireland  
Joint health and social care agencies (eg  
community mental health teams)  
Local authorities  
Phase 1 trial units  
Prison establishments  
Probation areas  
Independent (private or voluntary sector)  
organisations  
Educational establishments  
Independent research units  
Other (give details)  




A76. Insurance/ indemnity to meet potential legal liabilities 
 
Note: in this question to NHS indemnity schemes include equivalent schemes provided by Health and Social 
Care (HSC) in Northern Ireland 
 
A76-1. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of the 
sponsor(s) for harm to participants arising from the management of the research? Please tick box(es) as applicable. 
 
Note: Where a NHS organisation has agreed to act as sponsor or co-sponsor, indemnity is provided through NHS schemes. 
Indicate if this applies (there is no need to provide documentary evidence). For all other sponsors, please describe the 








NHS indemnity scheme will apply (NHS sponsors only) 
 
Other insurance or indemnity arrangements will apply (give details below) 
 
Lancaster University legal liability cover will apply. 
 
Please enclose a copy of relevant documents. 
 
 
A76-2. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability of the 
sponsor(s) or employer(s) for harm to participants arising from the design of the research? Please tick box(es) as 
applicable. 
 
Note: Where researchers with substantive NHS employment contracts have designed the research, indemnity is provided 
through NHS schemes. Indicate if this applies (there is no need to provide documentary evidence). For other protocol 
authors (e.g. company employees, university members), please describe the arrangements and provide evidence. 
 
NHS indemnity scheme will apply (protocol authors with NHS contracts only) 
 
Other insurance or indemnity arrangements will apply (give details below) 
 
Lancaster University legal liability cover will apply. 
 
Please enclose a copy of relevant documents. 
 
 
A76-3. What arrangements will be made for insurance and/ or indemnity to meet the potential legal liability 
of investigators/collaborators arising from harm to participants in the conduct of the research? 
 
Note: Where the participants are NHS patients, indemnity is provided through the NHS schemes or through professional 
indemnity. Indicate if this applies to the whole study (there is no need to provide documentary evidence). Where non-NHS sites 
are to be included in the research, including private practices, please describe the arrangements which will be made at these 
sites and provide evidence. 
 
NHS indemnity scheme or professional indemnity will apply (participants recruited at NHS sites only) 
 







































PART C: Overview of research sites 
 
 
Please enter details of the host organisations (Local Authority, NHS or other) in the UK that will be responsible for the  
research sites. For NHS sites, the host organisation is the Trust or Health Board. Where the research site is a primary care 
site, e.g. GP practice, please insert the host organisation (PCT or Health Board) in the Institution row and insert the research 




 Research site  Investigator/ Collaborator/ Contact 
 Institution name Merseycare NHS Trust Title Dr 
 Department name Community Memory Service First name/ 
Liliana  
Street address Park Road Initials    
    
 Town/city Liverpool Surname Loftus 
    
 Post Code L22 3XR    
      
      





















































   
 
 
PART D: Declarations 
 
D1. Declaration by Chief Investigator 
 
1. The information in this form is accurate to the best of my knowledge and belief and I take full responsibility for it. 
 
 
2. I undertake to abide by the ethical principles underlying the Declaration of Helsinki and good practice 
guidelines on the proper conduct of research. 
 
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full application as 
approved and any conditions set out by review bodies in giving approval. 
 
4. I undertake to notify review bodies of substantial amendments to the protocol or the terms of the approved 
application, and to seek a favourable opinion from the main REC before implementing the amendment. 
 
5. I undertake to submit annual progress reports setting out the progress of the research, as required by review 
bodies. 
 
6. I am aware of my responsibility to be up to date and comply with the requirements of the law and relevant 
guidelines relating to security and confidentiality of patient or other personal data, including the need to register 
when necessary with the appropriate Data Protection Officer. I understand that I am not permitted to disclose 
identifiable data to third parties unless the disclosure has the consent of the data subject or, in the case of patient 
data in England and Wales, the disclosure is covered by the terms of an approval under Section 251 of the NHS 
Act 2006. 
 
7. I understand that research records/data may be subject to inspection by review bodies for audit purposes if 
required. 
 
8. I understand that any personal data in this application will be held by review bodies and their operational 
managers and that this will be managed according to the principles established in the Data Protection Act 
1998. 
 
9. I understand that the information contained in this application, any supporting documentation and all 
correspondence with review bodies or their operational managers relating to the application: 
 
Will be held by the REC (where applicable) until at least 3 years after the end of the study; and by NHS 
R&D offices (where the research requires NHS management permission) in accordance with the NHS 
Code of Practice on Records Management.  
May be disclosed to the operational managers of review bodies, or the appointing authority for the REC 
(where applicable), in order to check that the application has been processed correctly or to investigate 
any complaint.  
May be seen by auditors appointed to undertake accreditation of RECs (where applicable).  
Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in response to 
requests made under the Acts except where statutory exemptions apply.  
May be sent by email to REC members. 
 
10. I understand that information relating to this research, including the contact details on this application, may be 
held on national research information systems, and that this will be managed according to the principles 
established in the Data Protection Act 1998. 
 
11. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I 
understand that the summary of this study will be published on the website of the National Research Ethics 
Service (NRES), together with the contact point for enquiries named below. Publication will take place no earlier 
than 3 months after issue of the ethics committee’s final opinion or the withdrawal of the application. 
 
 
Contact point for publication(Not applicable for R&D Forms) 
 
NRES would like to include a contact point with the published summary of the study for those wishing to seek further 





















Access to application for training purposes (Not applicable for R&D Forms) 
 
Optional – please tick as appropriate: 
 
I would be content for members of other RECs to have access to the information in the application in confidence 
 




This section was signed electronically by Miss Rachel Blackburn on 17/02/2016 13:41. 
 
Job Title/Post: Trainee Clinical Psychologist 

















































D2. Declaration by the sponsor's representative 
 
If there is more than one sponsor, this declaration should be signed on behalf of the co−sponsors by a representative of 
the lead sponsor named at A64-1. 
 
I confirm that: 
 
1. This research proposal has been discussed with the Chief Investigator and agreement in principle to 
sponsor the research is in place. 
 
2. An appropriate process of scientific critique has demonstrated that this research proposal is worthwhile and of 
high scientific quality. 
 
3. Any necessary indemnity or insurance arrangements, as described in question A76, will be in place before 
this research starts. Insurance or indemnity policies will be renewed for the duration of the study where 
necessary. 
 
4. Arrangements will be in place before the study starts for the research team to access resources and support to 
deliver the research as proposed. 
 
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of the research will be 
in place before the research starts. 
 
6. The duties of sponsors set out in the Research Governance Framework for Health and Social Care will be 
undertaken in relation to this research. 
 
Please note: The declarations below do not form part of the application for approval above. They will not be 
considered by the Research Ethics Committee. 
 
7. Where the research is reviewed by a REC within the UK Health Departments Research Ethics Service, I 
understand that the summary of this study will be published on the website of the National Research Ethics 
Service (NRES), together with the contact point for enquiries named in this application. Publication will take 
place no earlier than 3 months after issue of the ethics committee's final opinion or the withdrawal of the 
application. 
 
8. Specifically, for submissions to the Research Ethics Committees (RECs) I declare that any and all clinical trials 
approved by the HRA since 30th September 2013 (as defined on IRAS categories as clinical trials of 
medicines, devices, combination of medicines and devices or other clinical trials) have been registered on a 
publically accessible register in compliance with the HRA registration requirements for the UK, or that any 





This section was signed electronically by An authorised approver at ethics@lancaster.ac.uk on 08/03/2016 15:56. 
 
Job Title/Post: Research Support Officer 























   
 
 
D3. Declaration for student projects by academic supervisor(s) 
 
1. I have read and approved both the research proposal and this application. I am satisfied that the scientific content of 
the research is satisfactory for an educational qualification at this level. 
 
2. I undertake to fulfil the responsibilities of the supervisor for this study as set out in the Research Governance 
Framework for Health and Social Care. 
 
3. I take responsibility for ensuring that this study is conducted in accordance with the ethical principles underlying 
the Declaration of Helsinki and good practice guidelines on the proper conduct of research, in conjunction with 
clinical supervisors as appropriate. 
 
4. I take responsibility for ensuring that the applicant is up to date and complies with the requirements of the law and 
relevant guidelines relating to security and confidentiality of patient and other personal data, in conjunction with clinical 
supervisors as appropriate. 
 
Academic supervisor 1 
 
This section was signed electronically by  on 08/03/2016 13:08. 
 
 Job Title/Post: Director of Education, DHR 
 Organisation: Lancaster University 
 Email: j.simpson2@lancaster.ac.uk 
    
    








 West Midlands - Coventry & Warwickshire Research Ethics Committee  
The Old Chapel 
Royal Standard Place 
Nottingham  
NG1 6FS 
08 April 2016 
 
Mrs Rachel Watterson  






Dear Mrs Watterson 
 
Study title: Understanding self-conscious emotions: How partners 
 of individuals with vascular or Alzheimer’s dementia feel 
 about themselves 
REC reference: 16/WM/0154 
IRAS project ID: 189244 
 
Thank you for your letter responding to the Proportionate Review Sub-Committee’s 
request for changes to the documentation for the above study. 
 
The revised documentation has been reviewed and approved by the sub-committee. 
 
We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three 
months from the date of this favourable opinion letter. The expectation is that this 
information will be published for all studies that receive an ethical opinion but should 
you wish to provide a substitute contact point, wish to make a request to defer, or 




Under very limited circumstances (e.g. for student research which has received an 
unfavourable opinion), it may be possible to grant an exemption to the publication of 
the study. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised. 






The REC favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
Management permission must be obtained from each host organisation prior to the start of 
the study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given permission 
for the research to proceed (except where explicitly specified otherwise). 
 
Guidance on applying for HRA Approval (England)/ NHS permission for research is available in the 
Integrated Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites (“participant identification centre”), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations. 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database. This should be before the first participant is recruited but no 
later than 6 weeks after recruitment of the first participant. 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details as part of 
the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they 
should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be 
registered, however, in exceptional circumstances non registration may be permissible with prior 
agreement from the HRA. Guidance on where to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 













Copies of advertisement materials for research participants [Poster] 1 17 February 2016 
    
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 1 11 March 2016 
only) [Insurance1]     
GP/consultant information sheets or letters [GP Letter] 1 06 April 2016 
    
Interview schedules or topic guides for participants [Interview 1 17 February 2016 
Schedule]     
IRAS Checklist XML [Checklist_11032016]  11 March 2016 
    
IRAS Checklist XML [Checklist_06042016]  06 April 2016 
    
Letter from sponsor [Sponsor Letter] 1 11 March 2016 
    
Letters of invitation to participant [Expression of Interest] 1 17 February 2016 
    
Other [Insurance 2] 1 11 March 2016 
    
Other [Insurance 3] 1 11 March 2016 
    
Other [Response Letter] 1 06 April 2016 
    
Other [Lone Working Policy] 1 06 April 2016 
    
Other [Safeguarding Policy] 1 06 April 2016 
    
Participant consent form [Consent Form] 2 06 April 2016 
    
Participant information sheet (PIS) [Participant Info Sheet] 3 04 April 2016 
    
REC Application Form [REC_Form_09032016]  09 March 2016 
    
Research protocol or project proposal [Protocol] 2 04 April 2016 
    
Summary CV for Chief Investigator (CI) [CI CV] 1 17 February 2016 
    
Summary CV for supervisor (student research) [Supervisor CV] 1 17 February 2016 
     
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 




The attached document “After ethical review – guidance for researchers” gives detailed guidance 
on reporting requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments  Adding 
new sites and investigators 
 Notification of serious breaches of the protocol  
Progress and safety reports  
 Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes in 




You are invited to give your view of the service that you have received from the National Research 






feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality-
assurance 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/ 
 
16/WM/0154 Please quote this number on all correspondence 
 
 













Enclosures: “After ethical review – guidance for researchers” 
 
Copy to: Ms Debbie Knight 
 





































Mrs Rachel Watterson   
Clinical Psychology, Division of Health Research Email:  hra.approval@nhs.net 
Lancaster University   
Lancaster   
LA1 4YT   
06 July 2016   
Dear Mrs Watterson,   
   
 Letter of HRA Approval for a study  
 processed through pre-HRA  
 Approval systems  
   
Study title: Understanding self-conscious emotions: How partners of 
 individuals with vascular or Alzheimer’s dementia feel about 
 themselves  
IRAS project ID: 189244  
Sponsor: Lancaster University  
 
 
Thank you for your request for HRA Approval to be issued for the above referenced study. 
 
 
I am pleased to confirm that the study has been given HRA Approval. This has been issued on the 
basis that the study is compliant with the UK wide standards for research in the NHS. 
 
 
The extension of HRA Approval to this study on this basis allows the sponsor and participating NHS 
organisations in England to set-up the study in accordance with HRA Approval processes, with 
decisions on study set-up being taken on the basis of capacity and capability alone. 
 
 
If you have submitted an amendment to the HRA between 23 March 2016 and the date of this letter, 
this letter incorporates the HRA Approval for that amendment, which may be implemented in 
accordance with the amendment categorisation email (e.g. not prior to REC Favourable Opinion, 
MHRA Clinical Trial Authorisation etc., as applicable). 
 
 
It is not expected that any other NHS organisations in England will participate in this study. If 
subsequent NHS organisations in England are added, an amendment should be submitted to the 
HRA, providing a Statement of Activities and Schedule of Events, upon which a full HRA assessment 














IRAS project ID 189244 
  
 
Participation of NHS Organisations in England 
 
Please note that full information to enable set up of participating NHS organisations in England is not 




The sponsor should provide a copy of this letter, together with the local document package and a list 
of the documents provided, to participating NHS organisations in England that are being set up in 
accordance with HRA Approval Processes. It is for the sponsor to ensure that any documents 
provided to participating organisations are the current, approved documents. 
 
 
It is critical that you involve both the research management function (e.g. R&D office and, if the study 
is on the NIHR portfolio, the LCRN) supporting each organisation and the local research team (where 
there is one) in setting up your study. Contact details and further information about working with the 




After HRA Approval 
 
In addition to the document, “After Ethical Review – guidance for sponsors and investigators”, issued 
with your REC Favourable Opinion, please note the following: 
 
 HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 
notified in writing by the HRA.
2. Substantial amendments should be submitted directly to the Research Ethics Committee, as 
detailed in the After Ethical Review document. Non-substantial amendments should be 
submitted for review by the HRA using the form provided on the HRA website, and emailed to 
hra.amendments@nhs.net.  
3. The HRA will categorise amendments (substantial and non-substantial) and issue confirmation 









If your study involves NHS organisations in other countries in the UK, please contact the relevant 




If there are participating non-NHS organisations, local agreement should be obtained in accordance 





The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the appl ication 
procedure. If you wish to make your views known please email the HRA at hra.approval@nhs.net.  
Additionally, one of our staff would be happy to call and discuss your experience of HRA Approval. 
 













We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/. 
 
 
If you have any queries about the issue of this letter please, in the first instance, see the further 
information provided in the question and answer document on the HRA website. 
 
 
















Copy to: Ms Debbie Knight, Lancaster University 
 





































Notice of Amendment IRAS Version 5.3.2 
 
 
Welcome to the Integrated Research Application System 
 
IRAS Project Filter 
 
 
The integrated dataset required for your project will be created from the answers you give to the following questions. The 
system will generate only those questions and sections which (a) apply to your study type and (b) are required by the 
bodies reviewing your study. Please ensure you answer all the questions before proceeding with your applications. 
 
Please complete the questions in order. If you change the response to a question, please select ‘Save’ and review all the 
questions as your change may have affected subsequent questions. 
 
 
Please enter a short title for this project (maximum 70 characters)  
Self-conscious emotions in partners of people with dementia 
 
1. Is your project research? 
 
 Yes  No 
 
 
2. Select one category from the list below: 
 
Clinical trial of an investigational medicinal product 
 
Clinical investigation or other study of a medical device 
 
Combined trial of an investigational medicinal product and an investigational medical device 
 
Other clinical trial to study a novel intervention or randomised clinical trial to compare interventions in clinical practice 
 
Basic science study involving procedures with human participants 
 
Study administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative  
methodology 
 
Study involving qualitative methods only 
 
Study limited to working with human tissue samples (or other human biological samples) and data (specific project  
only) 
 
Study limited to working with data (specific project only) 
 




If your work does not fit any of these categories, select the option below: 
 
 Other study 
 
 
2a. Please answer the following question(s):   
a) Does the study involve the use of any ionising radiation? Yes No 
b) Will you be taking new human tissue samples (or other human biological samples)? Yes No 
c) Will you be using existing human tissue samples (or other human biological samples)? Yes No 
   
   






England   





















This study does not involve the NHS 
 
 
4. Which applications do you require? 
 
 
IMPORTANT: If your project is taking place in the NHS and is led from England select 'IRAS Form'. If your project is led 
from Northern Ireland, Scotland or Wales select 'NHS/HSC Research and Development Offices' and/or relevant 
Research Ethics Committee applications, as appropriate. 
 
 IRAS Form  
NHS/HSC Research and Development offices 
 
Social Care Research Ethics Committee 
 
Research Ethics Committee  
 Confidentiality Advisory Group (CAG)  
National Offender Management Service (NOMS) (Prisons & Probation) 
 
For NHS/HSC R&D Offices in Northern Ireland, Scotland and Wales the CI must create NHS/HSC Site 
Specific Information forms, for each site, in addition to the study wide forms, and transfer them to the PIs 
or local collaborators. 
 
For participating NHS organisations in England different arrangements apply for the provision of site 
specific information. Refer to IRAS Help for more information. 
 
 
5. Will any research sites in this study be NHS organisations? 
 
 Yes       No 
 
 
5a. Are all the research costs and infrastructure costs (funding for the support and facilities needed to carry 
out research e.g. NHS Support costs) for this study provided by a NIHR Biomedical Research Centre, NIHR 
Biomedical Research Unit, NIHR Collaboration for Leadership in Health Research and Care (CLAHRC), NIHR 
Patient Safety Translational Research Centre or a Diagnostic Evidence Co-operative in all study sites? 
 
Please see information button for further details. 
 
 Yes       No 
 
Please see information button for further details. 
 
 
5b. Do you wish to make an application for the study to be considered for NIHR Clinical Research Network 
(CRN) Support and inclusion in the NIHR Clinical Research Network Portfolio? 
 
Please see information button for further details. 
 
 Yes       No 
 
The NIHR Clinical Research Network provides researchers with the practical support they need to make clinical studies 









If you select yes to this question, you must complete a NIHR Clinical Research Network (CRN) Portfolio Application Form 
(PAF) immediately after completing this project filter question and before submitting other applications. Failing to complete the 
PAF ahead of other applications e.g. HRA Approval, may mean that you will be unable to access NIHR CRN Support for your 
study. 
 
6. Do you plan to include any participants who are children? 
 
 Yes       No 
 
 
7. Do you plan at any stage of the project to undertake intrusive research involving adults lacking capacity to 
consent for themselves? 
 
 Yes       No 
 
Answer Yes if you plan to recruit living participants aged 16 or over who lack capacity, or to retain them in the study following 
loss of capacity. Intrusive research means any research with the living requiring consent in law. This includes use of 
identifiable tissue samples or personal information, except where application is being made to the Confidentiality Advisory 
Group to set aside the common law duty of confidentiality in England and Wales. Please consult the guidance notes for 
further information on the legal frameworks for research involving adults lacking capacity in the UK. 
 
8. Do you plan to include any participants who are prisoners or young offenders in the custody of HM Prison Service 
or who are offenders supervised by the probation service in England or Wales? 
 




9. Is the study or any part of it being undertaken as an educational project? 
 
 Yes       No 
 
Please describe briefly the involvement of the student(s):  
The lead researcher (Rachel Blackburn) is currently enrolled on the Clinical Psychology Doctoral programme at 
Lancaster University. The lead researcher will be supervised by both Lancaster University staff and NHS staff. 
 
 
9a. Is the project being undertaken in part fulfilment of a PhD or other doctorate? 
 
 Yes       No 
 
 
10. Will this research be financially supported by the United States Department of Health and Human Services or any 
of its divisions, agencies or programs? 
 
 Yes       No 
 
 
11. Will identifiable patient data be accessed outside the care team without prior consent at any stage of the 
project (including identification of potential participants)? 
 



















NOTICE OF SUBSTANTIAL AMENDMENT 
 
Please use this form to notify the main REC of substantial amendments to all research other than clinical trials of 
investigational medicinal products (CTIMPs).  
The form should be completed by the Chief Investigator using language comprehensible to a lay person. 
 
 
Details of Chief Investigator:  
 Title Forename/Initials Surname 
 Mrs Rachel Watterson 
Work Address Clinical Psychology, Division of Health Research 
 Lancaster University  
 Lancaster  
PostCode LA1 4YT  
Email r.watterson@lancaster.ac.uk 
Telephone 01524 592970  
Fax    
    
    
 
For guidance on this section of the form refer to the guidance 
 
 








Name of REC: 
 
 
Understanding self-conscious emotions: How partners of individuals 











REC reference number: 16/WM/0154 
  
Additional reference number(s):  








Date study commenced: 
 
 
Protocol reference (if applicable), 
current version and date: 
 








Version 3, 18.10.16 
 
Amendment number and date: Amendment 1, 18.10.16 
 
 
Type of amendment 
 
(a) Amendment to information previously given in IRAS 
 
 Yes       No 
 








In 'participants' section of protocol method, it was previously stated that only individuals whose partner has a 
diagnosis of Alzheimer's disease, vascular or mixed dementia would be included in the study. However, I now wish 
to expand this criteria to people whose partner has a diagnosis of any type of dementia. Therefore, the title of the 
research paper has removed the words to 'Alzheimer's or vascular' to reflect the inclusion of all types of dementia. 
 
 
(b) Amendment to the protocol 
 
 Yes       No 
 
If yes, please submit either the revised protocol with a new version number and date, highlighting changes in 
bold, or a document listing the changes and giving both the previous and revised text. 
 
See amended protocol, version 3, dated 18.10.16. 
 
(c) Amendment to the information sheet(s) and consent form(s) for participants, or to any other supporting 
documentation for the study 
 
 Yes       No 
 
If yes, please submit all revised documents with new version numbers and dates, highlighting new text in bold. 
 
 
Is this a modified version of an amendment previously notified and not approved? 
 
 Yes       No 
 
 
Summary of changes 
 
Briefly summarise the main changes proposed in this amendment. Explain the purpose of the changes and their 
significance for the study.  
If this is a modified amendment, please explain how the modifications address the concerns raised previously by the 
ethics committee.  
If the amendment significantly alters the research design or methodology, or could otherwise affect the scientific value 
of the study, supporting scientific information should be given (or enclosed separately). Indicate whether or not 
additional scientific critique has been obtained. 
 
The original inclusion criteria of this study was to include only partners of people living with a diagnosis of Alzheimer's 
disease, vascular or mixed dementia. However, it is now proposed that the inclusion criteria will be expanded to include 
partners of people living with any type of dementia. It is anticipated that widening this criteria will provide more 
participants with the opportunity to share their experiences and take part in the study. Additionally, as the interviews are 
focused upon the experiences of the partner, rather than the person living with dementia, it is not anticipated that the 
type of dementia will have a significant impact on the partner's experience. Furthermore, all participants will continue to 




Any other relevant information 
 




List of enclosed documents 
 
 Document Version Date 
 Protocol_RW_V3_181016_Tracked 3 18/10/2016  
 Protocol_RW_V3_181016 3 18/10/2016  
     
     
     
 











1. I confirm that the information in this form is accurate to the best of my knowledge and I take full 
responsibility for it.  





This section was signed electronically by Miss Rachel Blackburn on 18/10/2016 21:14. 
 
Job Title/Post: Trainee Clinical Psychologist 





Declaration by the sponsor's representative 
 
I confirm the sponsor's support for this substantial amendment. 
 
 
This section was signed electronically by An authorised approver at ethics@lancaster.ac.uk on 26/10/2016 
09:45. 
 
Job Title/Post: Research Support and Systems Manager 


































West Midlands - Coventry & Warwickshire Research Ethics 
Committee  
The Old Chapel 




Please note: This is the 
favourable opinion of the 
REC only and does not 
allow the amendment to 
be implemented at NHS 
sites in England until the 
outcome of the HRA 
assessment has been 
confirmed. 
 
25 November 2016 
 
Mrs Rachel Watterson 
Clinical Psychology, Division of Health Research 





Dear Mrs Watterson, 
 
Study title: Understanding self-conscious emotions: How partners of 
 individuals with vascular or Alzheimer’s dementia feel about 
 themselves 
REC reference: 16/WM/0154 
Amendment number: Substantial Amendment 1, 18.10.16 
Amendment date: 18 October 2016 
IRAS project ID: 189244 
 
The above amendment was reviewed on 25 November 2016 by the Sub-




The members of the Committee taking part in the review gave a favourable ethical 
opinion of the amendment on the basis described in the notice of amendment form 
















Notice of Substantial Amendment (non-CTIMP) Substantial  18 October 2016 
 Amendment   
 1, 18.10.16   
Research protocol or project proposal [Track Changes] 3  18 October 2016 
    
Research protocol or project proposal [Clean] 3  18 October 2016 
     
 
Membership of the Committee 
 
The members of the Committee who took part in the review are listed on the 
attached sheet. 
 
Working with NHS Care Organisations 
 
Sponsors should ensure that they notify the R&D office for the relevant NHS care 
organisation of this amendment in line with the terms detailed in the categorisation 
email issued by the lead nation for the study. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/ 
 













Enclosures: List of names and professions of members who took part in the  
review 
 
Copy to: Ms Karen Bruce, Merseycare NHS Trust  






West Midlands - Coventry & Warwickshire Research Ethics Committee 













     
         
Dr Helen Brittain (Chair)  Clinical Psychologist  Yes    
   Retired      
        
Dr  Karen Schofield  Retired Consultant  Yes    
   Haematologist      
         
 
Also in attendance: 
 
 Name  Position (or reason for attending) 
    
Ms Teagan Allen  REC Assistant 
   
Ms Daniella Sarno  REC Assistant 








































IRAS 189244. SA 1. HRA Assessment Amendment Outcome 




 Blackburn, Rachel; Ethics (RSO) Enquiries  
Cc: 




Dear Mrs Watterson, 
 
Further to the below, I am pleased to confirm that HRA Approval has been issued for the referenced 
amendment, following assessment against the HRA criteria and standards. 
The sponsor should now work collaboratively with participating NHS organisations in England to implement 
the amendment as per the below categorisation information.  This email may be provided by the sponsor to 
participating organisations in England to evidence that the amendment has HRA Approval. 





Beverley Mashegede |  Assessor 
Health Research Authority 
Nottingham HRA Centre, The Old Chapel, 
Royal Standard Court, Nottingham NG1 6FS 
































‘Understanding self-conscious emotions: How partners of people living with dementia feel 
about themselves’ 
 
Before you consent to participating in the study we ask that you read the participant information 
sheet and mark each box below with your initials if you agree. If you have any questions or 





box after each 
statement 
 
1. I confirm that I have read the information sheet and 
fully understand what is expected of me within this 
study 
 
2. I confirm that I have had the opportunity to ask any 
questions and to have them answered. 
3. I understand that my interview will be audio recorded and then made 
into an anonymised written transcript. I understand that audio recordings will 
be kept until the research project has been examined. 
 
4. I understand that after consenting to take part in the study, I 
can choose to withdraw up to two weeks after my interview 
has been conducted. If I choose to withdraw up to this point 
my interview data will be destroyed and not used in the final 
study; however if I choose to withdraw after this point my 
data will remain in the study. 
5. I understand that the information from my interview will be 
pooled with other participants’ responses, anonymised and 
may be published 
 
6. I consent to information and quotations from my interview 
being used in reports, conferences and training events. 
 
7. I understand that any information I give will remain strictly 
confidential and anonymous unless it is thought that there is a 
risk of harm to you, myself or others. In this case the principal 






appropriate emergency services and the supervisors of the 
project, even without my consent. 
 
 
8. I consent to Lancaster University keeping written 
transcriptions of the interview for 10 years after the study has 
finished. 
 
9. I consent for a letter to be sent to my GP informing them of 
my participation in the study. 
 







Name of Participant__________________ Signature____________________ Date ___________ 
 
















































Appendix 9  







Participant Information Sheet 
 
  
‘Understanding self-conscious emotions: How partners of individuals with dementia feel about 
themselves’ 
  
My name is Rachel Watterson and I am conducting this research as a trainee clinical psychologist at 
Lancaster University, Lancaster.  
  
What is the study about?  
The purpose of this study is to explore how you feel about yourself as a partner of someone with a 
diagnosis of dementia. Additionally, the study will explore if there are differences in how you felt 
about yourself prior to and now following your partner’s diagnosis of dementia.  
  
It is anticipated that this information will develop our current understanding of the emotional 
experiences of partners, which may impact upon their psychological and physical wellbeing. 
Furthermore, these findings aim to inform the type of support systems which should be in place 
around the individual with dementia and their partner. The findings may also inform the pathway for 
future research in this area.  
  
Why have I been approached?  
You have been approached because the study requires information from individuals who currently 






purposes of this research the term partner refers to individuals who have lived with and have been in 
a relationship with an individual with dementia for five years prior to the dementia diagnosis.  
 
Do I have to take part?  
No. It’s completely up to you to decide whether or not you take part, there is no obligation. You can 
contact the lead researcher, Rachel Watterson, via telephone or complete the expression of interest 
form so that the lead researcher can contact you if you have any questions or queries regarding 
participating in the research.  
  
What will I be asked to do if I take part?  
If you decide you would like to take part, you would be asked to read and sign a consent form, 
detailing the requirements of your participation. The lead researcher will contact you to arrange a 
suitable time to meet at your local memory clinic or GP surgery for an interview; alternatively home 
visits can be arranged if this is more suitable. The interview will last around an hour although this 
can be shorter or longer depending on what you wish to discuss and any other commitments you 
have. The interview will discuss the emotions you have and this will constitute as your participation 
in the study.  
  
Will my data be confidential?  
The information you provide is confidential, unless you disclose information that puts you or other 
people at risk. You will also be asked to create an alternative name for yourself, which you will be 
referred by throughout the research project. Additionally, the lead researcher will ensure that you 







The following steps will also be taken to ensure that the information you provide is protected and 
remains confidential.  
  
 During the undertaking of the project, the transcripts will be saved in password protected 
documents and stored electronically on the university’s Virtual Private Network (VPN).  
 All paper documents (e.g. consent forms) will be locked in a secure cabinet, only accessible 
by the lead researcher.  
 Upon completion of the project all paper documents will be destroyed by the lead researcher.  
 Other than the lead researcher, only the academic supervisor, who is not employed by the 
NHS, of the project will have access to the anonymised transcripts while the project is being 
conducted. Additionally, the academic supervisor will listen to the audio recording of the 
first interview providing that your name is not included.  
 All personal participant information will be confidential and participants’ details will be 
anonymised. This includes the transcribed version of your interview being made anonymous 
by removing any personally identifying information such as your name. Anonymised direct 
quotations from your interview may be used in the reports or publications from the study, 
but your name will not appear in the final write up or publications.  
  
There are some limits to confidentiality: if what is said in the interview makes me think that you, or 
someone else, is at significant risk of harm, I will have to break confidentiality and potentially 
inform the emergency services.   
  






The results will be summarised and reported in a thesis research project for Lancaster University, 
Doctorate in Clinical Psychology course and will be submitted for publication in a peer-reviewed 
academic journal.  
  
Can I withdraw from the study?  
After consenting to take part in the study, you can choose to withdraw up to two weeks after your 
interview has been conducted. If you choose to withdraw up to this point your interview data will be 
destroyed and not used in the final study; however if you choose to withdraw after this point your 
data will remain in the study.  
  
Are there any risks?  
There are no risks anticipated with participating in this study. However, if you experience any 
distress following participation you are provided with the contact details for several resources at the 
end of this sheet. Additionally, with your permission the researcher will send a letter to your GP 
informing them of your participation so that they can provide any additional support you may 
require.  
  
Are there any benefits to taking part?  
Although you may find participating interesting and the results may contribute to the development 
of support provisions within memory and older adult services, there are no direct benefits in taking 
part.  
 
 Who has reviewed the project? 
 This study has been reviewed by Coventry & Warwickshire Research Ethics Committee. Research 






submit a complaint about the study, please contact Professor Bruce Hollingsworth at Lancaster 
University on the below contact details.  
  
Where can I obtain further information about the study if I need it?  
If you have any questions about the study, please contact the main researcher:  
  
Rachel Watterson  
Address: Clinical Psychology, Division of Health Research, Lancaster University, Lancaster, LA1 
4YT Phone: 07508406248 Email: r.watterson@lancaster.ac.uk  
  
Complaints 
 If you wish to make a complaint or raise concerns about any aspect of this study and do not want to 
speak to the researcher, you can contact:  
  
Professor Bruce Hollingsworth, Lancaster University Head of the Division of Health Research,  
Tel: (01524) 592127    
Email:b.hollingsworth@lancaster.ac.uk   
Faculty of Health and Medicine (Division of Health Research) Furness Building Lancaster 
University Lancaster LA1 4YG  
  










Resources in the event of distress  
Should you feel distressed either as a result of taking part, or in the future, the following resources 
may be of assistance. You should also speak to your GP should you feel distressed or require mental 
health support.  
  
The Carers Trust Sefton Carers Centre 27-37 South Road Waterloo L22 5PE 0151 288 6060  
 www.seftoncarers.org.uk  
  
Living Well Centre 25-35 Scarisbrick Avenue Southport PR8 1NW 0151 288 6890  
www.livingwellcentre.org.uk  
  
Carers Project Local Solutions Mount Vernon Green Hall Lane Liverpool L7 8TF  
www.localsolutions.org.uk/projects/carers/  
  
Alzheimer’s Society www.alzheimers.org.uk  
  






























                                                                                                 
 
                                                                                                                 
 
Expression of Interest Form 
  
‘Understanding self-conscious emotions: How partners of individuals with dementia feel about 
themselves’ 
  
I would like to express an interest in participating in the above research. I provide my consent for the 
principal investigator, Rachel Watterson, to contact me on the details that I have provided below, to 
discuss my participation in the project further. I understand that by completing this form, I am not 
consenting to participating in the study. It is a no obligation expression of my interest.  
  
  
Name of potential participant:  
Contact telephone number:  
  


























Clinical Psychology, Div. Of Health Research  
Lancaster University  
Lancaster  
LA1 4YT  
  
 Phone: 07508406248   
Email: r.watterson@lancaster.ac.uk    
2016  
Dear Dr   
Re:              D.O.B:   
I am writing to inform you that the above patient has participated in the following research;   
‘Understanding self-conscious emotions: How partners of individuals with dementia feel about 
themselves.’  
 
This study has been reviewed by Coventry & Warwickshire Research Ethics Committee. While 
there are no anticipated risks with participating in this study, participants have been provided with 
the contact details for their local carers centre and Alzheimer’s Society. Additionally, participants 
have been encouraged to seek support from their GP should they experience any distress or require 
additional support following participation in the study.  
Yours Sincerely  
  
Rachel Watterson  














‘Understanding self-conscious emotions: How partners of individuals with dementia feel about 
themselves’ 
 
 Background to research; purpose and structure of interview; issues of confidentiality and 
consent; sign consent form; any questions. Ask age of participant and partner, how long they 
have been in relationship (years), length of time living together (years) current support 
systems in place (informal and formal) and how long since diagnosis (months) (approx. 5 
minutes)  
 
Pre-diagnosis (approx. 20 minutes):  
 What did you do before you cared for your partner?  
 What were you like as a person then?   
 How would you describe how you felt about yourself prior to your partner’s diagnosis? (I.e. 
laid back, critical, compassionate, positive/negative, accomplished, proud, not good enough)  
 Were you happy with feeling like this or would have liked to change the way you felt about 
yourself? 
 How would you have felt towards yourself when you had achieved something or other 
people had recognised you doing something well? Were you comfortable feeling like this?  
 How would you have felt towards yourself when you thought you had made a mistake or 






 Where there differences in your how you felt about yourself and how you felt about other 
people? I.e. more critical of self or more critical of others? If so, why?  
 
 
Post-diagnosis (approx. 40 minutes):  
 Has caring for your partner changed you as a person? If it has, how?  
 Can you compare yourself to how you were before you cared for your partner? 
 How would you describe your general attitude towards yourself since to your partner’s 
diagnosis? (I.e. laid back, critical, compassionate, positive/negative). Why do you think this 
has/has not changed since diagnosis? 
 Does this change depending on the situation you were in or is it mainly consistent? Could 
you give me an example?  
 Would you like to change how you feel about yourself? In what way?  
 Do you think this helps when dealing with difficult situations? If so, how? Example? 
 How do you feel towards yourself when you achieve something or other people recognise 
you do something well? Are you more/less comfortable feeling like this than previously?  
 How do you have feel about yourself when you think you have made a mistake or something 
has not gone well for you? How do you cope with this?  
 Do you think this affects your relationships with other people, in particular your partner? 
Example? 
 Do you think this affects any other aspect of your functioning? (E.g. motivation, being goal 
driven, mood, keep up with hobbies and interest).  
 


















Interested in taking part in research? 
 Has your partner had a diagnosis of dementia for more than two years? 
 Do they live at home with you? 
 If yes, would you be willing to be interviewed about your experiences of how 
you feel about yourself as a partner of someone with dementia? 
 
 Contact the researcher directly: 
Rachel Watterson 
r.watterson@lancaster.ac.uk         Phone: 07508406248 
Or request an Expression of Interest form from your memory nurse
   
 
 
